New Amida Care Study: ART Type and Adherence and Viral Suppression
August 21 2023
This study, which Amida Care conducted with the Brookdale Center for Healthy Aging at CUNY Hunter and funding support from Gilead, explores how viral suppression varies by antiretroviral therapy (ART) type when a person’s treatment adherence level is lower than 90%. Read more